Contextual Genomics is focused on improving cancer treatment and patient outcomes by combining state of the art genomic testing with AI powered analysis of patient data. The aim is to improve the management of cancer through better diagnosis and treatment. Contextual's products use next generation sequencing (NGS) and a proprietary cloud based platform to analyse the test data and report to the requesting physician. = Key products: 1. FIND IT - genomic test that detects cancer related mutations in solid tissue. This test looks for known mutations in solid tumor cancers that are treatable with existing therapies. 2. FOLLOW IT - genomic test that detects cancer related mutations in blood plasma. FOLLOW IT can inform oncologists of treatment options and be used to evaluate patient response and relapse over time. Contextual has additional products in development that will seek to marry these products with further


BIOTECHNOLOGY

View Details...